New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer. The US Preventive Services Task Force says that women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have ancestry associated with BRCA1 and BRCA2 gene mutations should undergo risk assessment and, if indicated, genetic counseling and testing. More Women Should Consider BRCA Test to Assess Breast Cancer Risk, New Guidelines Say